Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Efstathiou

Showing results (81-90 of 273) with videos related to

Pageof 28
Sort By:
Plos One|December 26, 2024
Effect of concentric exercise-induced fatigue on proprioception, motor control and performance of the upper limb in handball playersStelios Hadjisavvas, Michalis A Efstathiou, Irene-Chrysovalanto Themistocleous, et al.
Journal of Clinical Gastroenterology|January 1, 1999
Gastrin-regulated expression of p53 in transformed enterochromaffin-like cells in the African rodent mastomysE A Luque, L H Tang, K H Bortecen, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 24, 2025
Molecular tumor volume on PSMA PET/CT is an independent imaging biomarker associated with progression-free survival in patients with oligorecurrent prostate cancerMonica Cheng, Umar Mahmood, Nathaniel D Mercaldo, et al.
Prostate Cancer and Prostatic Diseases|May 20, 2021
<sup>18</sup>F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic reviewSoroush Rais-Bahrami, Jason A Efstathiou, Catriona M Turnbull, et al.
European Urology|February 5, 2008
Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02Jason A Efstathiou, Kyounghwa Bae, William U Shipley, et al.
Clinical Genitourinary Cancer|April 11, 2021
Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder CancerTrevor J Royce, Yuan Liu, Matthew I Milowsky, et al.
Clinical Genitourinary Cancer|November 29, 2018
Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder CancerTrevor J Royce, Adam S Feldman, Matthew Mossanen, et al.
JAMA Network Open|May 16, 2022
Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific MortalityLaura Burgess, Christopher M Aldrighetti, Anushka Ghosh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31Jason A Efstathiou, Kyounghwa Bae, William U Shipley, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2011
Comparison of high-dose proton radiotherapy and brachytherapy in localized prostate cancer: a case-matched analysisJohn J Coen, Anthony L Zietman, Carl J Rossi, et al.
Pageof 28

Showing results (81-90 of 273) with videos related to

Sort By:
Pageof 28
Plos One|December 26, 2024
Effect of concentric exercise-induced fatigue on proprioception, motor control and performance of the upper limb in handball playersStelios Hadjisavvas, Michalis A Efstathiou, Irene-Chrysovalanto Themistocleous, et al.
Journal of Clinical Gastroenterology|January 1, 1999
Gastrin-regulated expression of p53 in transformed enterochromaffin-like cells in the African rodent mastomysE A Luque, L H Tang, K H Bortecen, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 24, 2025
Molecular tumor volume on PSMA PET/CT is an independent imaging biomarker associated with progression-free survival in patients with oligorecurrent prostate cancerMonica Cheng, Umar Mahmood, Nathaniel D Mercaldo, et al.
Prostate Cancer and Prostatic Diseases|May 20, 2021
<sup>18</sup>F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic reviewSoroush Rais-Bahrami, Jason A Efstathiou, Catriona M Turnbull, et al.
European Urology|February 5, 2008
Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02Jason A Efstathiou, Kyounghwa Bae, William U Shipley, et al.
Clinical Genitourinary Cancer|April 11, 2021
Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder CancerTrevor J Royce, Yuan Liu, Matthew I Milowsky, et al.
Clinical Genitourinary Cancer|November 29, 2018
Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder CancerTrevor J Royce, Adam S Feldman, Matthew Mossanen, et al.
JAMA Network Open|May 16, 2022
Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific MortalityLaura Burgess, Christopher M Aldrighetti, Anushka Ghosh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31Jason A Efstathiou, Kyounghwa Bae, William U Shipley, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2011
Comparison of high-dose proton radiotherapy and brachytherapy in localized prostate cancer: a case-matched analysisJohn J Coen, Anthony L Zietman, Carl J Rossi, et al.
Pageof 28